At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
n-VNSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Invasive Neurostimulation of the Vagus Nerve With the GammaCore Device For the Relief of Symptoms Associated With Migraine
In Brief
A clinical study evaluating n-VNS for Migraine. Completed, enrolled 30 participants across 3 sites.
Detailed Summary
The purpose of this pilot study is to assess feasibility and clarify the design of future study(ies) to support marketing approval of the GammaCore™ device for the treatment and/or prevention of migraine symptoms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
First PostedFeb 2012
Primary CompletionJul 2012
Study CompletionJul 2012
TodayJul 2026
First PostedFeb 15, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJul 1, 2012
Study CompletionJul 25, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 14.4 years ago
Interventions
n-VNSdevice